Aaron Pelta
Corporate Officer/Principal bei MORPHIC HOLDING, INC.
Profil
Aaron Pelta's career history includes former positions as Vice President-Business Development & Transactions at AMAG Pharmaceuticals, Inc. in 2015, and Vice President-Business Development at X4 Pharmaceuticals (Austria) GmbH from 2016 to 2019.
He also holds a current position as Senior Vice President-Business & Development at Morphic Holding, Inc. starting in 2022.
Mr. Pelta obtained an undergraduate degree from Tufts University in 1996 and an MBA from Tuck School of Business at Dartmouth in 2002.
Aktive Positionen von Aaron Pelta
| Unternehmen | Position | Beginn |
|---|---|---|
| MORPHIC HOLDING, INC. | Corporate Officer/Principal | 01.01.2019 |
Ehemalige bekannte Positionen von Aaron Pelta
| Unternehmen | Position | Ende |
|---|---|---|
| X4 Pharmaceuticals (Austria) GmbH | Corporate Officer/Principal | 01.03.2019 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.11.2015 |
Ausbildung von Aaron Pelta
| Tufts University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
| X4 Pharmaceuticals (Austria) GmbH |
